• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 207/10 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 207/10

Total number of patents in this class: 170

10-year publication summary

11
21
11
8
12
7
9
5
9
1
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
F. Hoffmann-La Roche AG
7832
10
3m Innovative Properties Company
17536
10
Bodor Laboratories, Inc.
58
9
Corteva Agriscience LLC
2636
9
Hoffmann-La Roche Inc.
3665
7
Tetraphase Pharmaceuticals, Inc.
52
5
VALO Health, Inc.
184
5
Daiichi Sankyo Company, Limited
1881
4
Novartis AG
10376
3
Bayer Pharma AG
1028
3
California Institute of Technology
4011
3
KYORIN Pharmaceutical Co., Ltd.
162
3
Taisho Pharmaceutical Co., Ltd.
859
3
Toyama Chemical Co., Ltd.
94
3
Rappta Therapeutics Oy
9
3
Bristol-myers Squibb Company
4814
2
AstraZeneca AB
2845
2
Allergan, Inc.
2225
2
Board of Regents, The University of Texas System
6018
2
The Regents of the University of Michigan
4890
2
Other owners 80